UTERINE/ENDOMETRIAL CANCER: CLINICAL EXOME PANEL (Sec. & CNVs) – 27 genes
LabGenetics
Delivery time
3-4 weeks
Sample
Blood
The Hereditary Uterine/Endometrial Cancer Panel studies genes involved in the genetic predisposition to endometrial carcinoma, both sporadic and associated with hereditary syndromes. It analyzes genes of the DNA repair pathway (MMR)—such as MLH1, MSH2, MSH6, PMS2, and EPCAM—involved in Lynch syndrome, as well as genes for susceptibility to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, PALB2, RAD51C, PTEN) and others related to Cowden (PTEN) and Peutz-Jeghers (STK11) syndromes. This panel allows for the development of screening strategies, personalized gynecological surveillance, and the selection of targeted treatments. Genes analyzed: MLH1, MSH2, MSH6, PMS2, BRCA1, BRCA2, PTEN, STK11, TP53, POLE, and others. You can consult the complete list of analyzed genes by contacting Genotica.
Other tests
Preventive health test - AboutMe EXOME
545,00€
NEUROFIBROMATOSIS: GENES SMARCB1 Y LZTR1 (NGS-Sec) – ATG Medical
600,00€
Custom sequencing panels (1 to 15 genes)
660,00€